|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
MEMBRANE TRANSPORTERS, ION CHANNELS, AND PUMPS
1Department of Ophthalmology and Visual Sciences, and 2Department of Pharmacology and Toxicology, University of Louisville, Louisville, Kentucky; 3Division of Mathematics and Science, St. Catharine College, St. Catharine, Kentucky; and 4Department of Physiology, University of Arizona, Tucson, Arizona
Submitted 16 November 2006 ; accepted in final form 23 May 2007
| ABSTRACT |
|---|
|
|
|---|
60 kDa was observed, suggesting not all Src family members are activated. Immunoprecipitation studies showed that band density of active Src, and to a lesser extent active Fyn, was significantly increased, while active Yes did not change. Preincubation of the lenses with SFK inhibitor PP2 abolished the ATP-induced increase in ouabain-sensitive potassium (86Rb) uptake. The results suggest selective activation of Src and/or Fyn is part of a signaling mechanism initiated by purinergic agonists that increases Na-K-ATPase-mediated transport in the organ-cultured lens. Src kinase; receptors
Various mechanisms are involved in the regulation of Na-K-ATPase function. While long-term regulation often involves changes in gene expression, previous studies have shown that short-term regulation can be achieved by phosphorylation events involving protein kinases (14, 42). The effects of serine/threonine kinases such as protein kinase C and protein kinase A have been studied extensively (3, 14, 42). In contrast, relatively little is known about the role of tyrosine kinases on Na-K-ATPase regulation, and research related to this topic has been emerging as an interesting area of study. Genistein, a general tyrosine kinase inhibitor, has been shown to abolish the change of Na-K-ATPase activity induced by various agonists in tissues, including kidney proximal tubule, lens, and ciliary epithelium (16, 32, 34, 35). Feraille and coworkers (15) have shown that the phosphorylation of Na-K-ATPase
1 catalytic subunit at Tyr10 is required for the insulin-induced stimulation of Na-K-ATPase activity in kidney proximal tubule cells.
Src family kinases (SFKs), a family of nonreceptor tyrosine kinases, have been shown to be involved in the regulation of Na-K-ATPase in the lens as well as several other cell types. Bozulic and colleagues (4) demonstrated that in vitro phosphorylation of a lens epithelial membrane and a kidney medulla membrane preparation by the SFK member Lyn results in decreased Na-K-ATPase activity. In alveolar epithelial cells, however, SFKs apparently have the opposite effect on Na-K-ATPase activity. Thyroid hormone increases alveolar cell Na-K-ATPase activity via SFK-dependent pathway (23). This fits with the finding that the direction of the change of Na-K-ATPase activity in a lens epithelium membrane preparation (decrease or increase) depended on the Src family kinase member used for the phosphorylation (5). This discovery points to a situation where activation of different SFKs could elicit different Na-K-ATPase responses. Here, we examined the Na-K-ATPase response of the lens to purinergic agonists.
Purinergic receptor signaling is involved in regulation of ion transport in various epithelial cell types (24). Furthermore, stimulation of P2Y receptors activates SFKs in various cell types (7, 19, 22, 26). Previous studies have shown that the lens expresses P2Y2 receptors (9–11) and that ATP is released under stress conditions from the lens as well as from ciliary epithelium, the tissue adjacent to the lens (13, 30). In the present study, effects of P2 receptor agonists on Na-K-ATPase activity and SFK activation in the organ-cultured rabbit lens were examined. Purinergic receptor agonists caused both an increase of the Na-K-ATPase activity and selective SFK activation. SFK activation was required for the change in Na-K-ATPase activity.
| MATERIALS AND METHODS |
|---|
|
|
|---|
Measurement of Rb uptake.
Ouabain-sensitive uptake of 86Rb was used as an index of Na-K-ATPase-mediated potassium transport activity in organ-cultured lenses. One-half the lenses received ouabain 15 min before the addition of purinergic receptor agonists. Purinergic receptor agonists (final concentration 100 µM) were added to lenses in Krebs solution 5 min before 86Rb. Each lens received 86Rb (
0.1 µCi/ml) added to the Krebs solution for a 30-min uptake period. The lenses were then washed in ice-cold nonradioactive Krebs solution, blotted dry on a filter paper, weighed, and dried overnight in an oven. Dried lenses were reweighed and weight loss was assessed to calculate lens water content. Dried lenses were digested in 30% nitric acid for 4 h at 70°C. Radioactivity of acid digests was measured using a scintillation counter. An aliquot of the loading solution was counted. On the basis of the specific activity of the loading solution (cpm/mol potassium), Na-K-ATPase-mediated potassium transport was calculated as nanomoles potassium per gram lens water per 30 min. The ratio of ouabain-sensitive to ouabain-insensitive 86Rb uptake was 75:25. In a time-course experiment, ouabain-sensitive 86Rb uptake was linear up to 60 min with an r2 value of 0.995.
Measurement of Na-K-ATPase activity. Ouabain-sensitive ATP hydrolysis was measured in homogenates of isolated lens epithelium. Lenses in Krebs solution were treated with or without 100 µM ATP for 5 min, followed by a 2-min wash in ice-cold Krebs solution. The lens capsule epithelium was then isolated from the fiber mass and homogenized in ice-cold ATPase assay solution composed of (in mM) 40 histidine, 100 NaCl, 10 KCl, 3 MgCl2, and 1 EGTA (pH 7.4) with 10 µg/ml alamethacin in the presence of protease inhibitors (2 µM antipain, 2 µM leupeptin, 1 µM peptastatin A, 1 mM phenylmethylsulfonyl fluoride, and 2 µg/ml aprotinin). The protein concentration in the homogenate was determined using the bicinchoninic acid assay (Pierce, Rockford, IL). Ouabain-sensitive ATPase activity of the homogenates was measured as previously described (34). One-half of the samples received ouabain (final concentration 100 µM). Homogenate protein (100 µg) in ATPase assay solution was preincubated for 5 min at 37°C in the presence of alamethicin, an ionophore previously found to permeabilize cell membranes to ions and ATP (47). ATP (final concentration of 1 mM) was then added to initiate the assay. The reaction was stopped at 45 min by the addition of 15% ice-cold trichloroacetic acid. Colorimetric method was used to quantify the amount of inorganic phosphate released by the ATP hydrolysis reaction. Na-K-ATPase activity was defined as the ouabain-sensitive (the difference in the presence and absence of ouabain) ATP hydrolysis. The ratio of ouabain-sensitive to ouabain-insensitive ATP hydrolysis was 60:40. The data are presented as nmol phosphate release/100 µg protein/min.
Immunoprecipitation and Western blot analysis. Lenses were incubated in the presence or absence of purinergic receptor agonists (final concentration 100 µM) for 5 min. Then the capsule epithelium was isolated and placed in ice-cold lysis buffer composed of (in mM) 50 HEPES, pH 7.5, 150 NaCl, 1 EDTA, 10 sodium fluoride, 10 sodium pyrophosphate, 2 sodium orthovanadate, 10% glycerol, 1% Triton X-100, 1% sodium deoxycholate, and protease inhibitors (2 µM antipain, 1 µM leupeptin, 1 µM pepstatin A, 1 mM phenylmethylsulfonyl fluoride, and 2 µg/ml aprotinin) for Western blot analysis or RIPA buffer I composed of (in mM) 50 HEPES, pH 7.5, 150 NaCl, 1 EDTA, 10 sodium fluoride, 10 sodium pyrophosphate, 2 sodium orthovanadate, 10% glycerol, 0.5% Triton X-100, 0.5% Nonidet P-40, 0.5% sodium dodecyl sulfate, and protease inhibitors (2 µM antipain, 1 µM leupeptin, 1 µM pepstatin A, 1 mM phenylmethylsulfonyl fluoride, and 2 µg/ml aprotinin) for SFK immunoprecipitation or RIPA buffer II composed of (in mM) 50 HEPES, pH 7.5, 150 NaCl, 1 EDTA, 10 sodium fluoride, 10 sodium pyrophosphate, 2 sodium orthovanadate, 10% glycerol, 0.5% deoxycholate, 1% Nonidet P-40, 0.1% sodium dodecyl sulfate, and protease inhibitors (2 µM antipain, 1 µM leupeptin, 1 µM pepstatin A, 1 mM phenylmethylsulfonyl fluoride, and 2 µg/ml aprotinin) for Na-K-ATPase immunoprecipitation. Protein concentration was determined by bicinchoninic acid assay. For immunoprecipitation, 500 µg of total protein (1 µg/µl) was incubated overnight at 4°C with the immunoprecipitation antibody: mouse monoclonal anti-Yes antibody (clone 1 from BD Bioscience, San Jose, CA) for Yes, mouse monoclonal anti-Src antibody (clone GD11) conjugated to agarose beads (Upstate Chemicon, Temecula, CA) for Src, goat polyclonal anti-Fyn antibody (Fyn3 from Santa Cruz Biotechnology, Santa Cruz, CA) for Fyn and mouse monoclonal anti-Na-K-ATPase antibody (clone C464.6) conjugated to agarose beads (Santa Cruz Biotechnology). For unconjugated antibodies (Yes and Fyn), immobilized protein G beads (Pierce) were added and further incubated for 4 h at 4°C. Beads were collected by centrifugation and washed three times with PBS. SDS sample buffer was added to the beads and incubated at 60°C for 20 min. Beads were spun down and the supernatant was used for Western blot analysis.
For Western blot analysis, 50 µg protein was used per sample. Proteins were separated on a 7.5% gel by SDS-PAGE and transferred to a nitrocellulose membrane. The membrane was blocked with blocking buffer (LICOR, Lincoln, NE) for 1 h at room temperature and incubated overnight at 4°C with rabbit polyclonal anti-PY416 Src antibody or rabbit polyclonal anti-PY527 Src (Cell Signaling Technology, Beverly, MA) or goat anti-Na-K-ATPase antibody (N-15 from Santa Cruz Biotechnology) for the Na-K-ATPase immunoprecipitates. The anti-PY416 Src antibody cross-reacts with SFK members phosphorylated at the active loop tyrosine (PYA-SFK) while the anti-PY527 Src antibody cross-reacts with SFK members phosphorylated at the COOH-terminal inhibitory tyrosine (PYT-SFK). After three 5-min washes with Tris-buffered saline + Tween 20, the nitrocellulose membrane was incubated for 1 h with anti-rabbit secondary antibody conjugated with IRDye 800 (Rockland Immunochemicals, Gilbertsville, PA) or anti-goat secondary antibody conjugated with Alexa Fluor 680 dye (Invitrogen). The membrane was washed three times and the bands detected and quantified using an Odyssey infrared scanner (LICOR, Lincoln, NE). The same membrane was washed and incubated overnight at 4°C with mouse monoclonal anti-Src (clone GD11; Upstate, Charlottesville, VA), anti-Yes (clone 1 from BD Bioscience), anti-Fyn antibody [Fyn (15) from Santa Cruz Biotechnology], mouse anti-phosphotyrosine antibody (clone PY20 from BD Bioscience), or anti-
-actin antibody (clone AC-74; Sigma, St. Louis, MO). Three 5-min washes were followed by 1 h incubation with anti-mouse secondary antibody conjugated with Alexa Fluor 680 dye (Invitrogen) or anti-mouse secondary antibody conjugated with IRDye 800 (Rockland Immunochemicals) for the Na-K-ATPase immunoprecipitates. After three washes, the membrane was scanned to detect and quantify the bands.
Statistical analysis. Student's t-test was used for statistical analysis.
| RESULTS |
|---|
|
|
|---|
|
1 protein isolated by immunoprecipitation from the epithelium of ATP-treated lenses showed no discernible difference in phosphotyrosine Western blot band density (Fig. 3).
|
|
5 min and returned to the basal level at 30 min (Fig. 6). Immunoprecipitation of SFK members Yes, Src, and Fyn was performed in an attempt to identify which family members are activated. Comparison of nonimmunoprecipitated samples with supernatants following immunoprecipitation revealed that immunoprecipitation efficiency was high for each SFK member with >80% of the target protein immunoprecipitated (data not shown). The band density of Yes protein phosphorylated at the active site was not significantly different in control and ATP-treated lenses, indicating that Yes is not activated by ATP treatment (Fig. 7A). In contrast, the abundance of active Src kinase was significantly increased (
60%) in the ATP-treated lenses as evidenced by the increased band density of Src kinase phosphorylated at the active site (Fig. 7B). The abundance of Fyn kinase phosphorylated at the active site was increased, but to a lesser extent (
25%) (Fig. 7C).
|
|
|
|
20%. 86Rb uptake was unaffected by PP3, an inactive analogue of PP2 used as a control.
|
| DISCUSSION |
|---|
|
|
|---|
Suramin abolished the potassium (86Rb) uptake response to ATP but as a purinergic receptor antagonist suramin is nonselective, making it difficult to be certain what receptor subtype is involved. On the basis of what is known about purinergic receptor selectivity, however, the similar-sized responses to ATP and UTP fit the profile of P2Y2 and possibly P2Y4 purinergic receptor activation (38, 44). Rabbit lenses have been previously reported to express P2Y2 receptor mRNA (11). ATP induces a transient rise of cytoplasmic calcium in the epithelium of the intact rabbit lens (40) and pharmacological studies of calcium signaling suggested P2Y2 (previously known as P2U) is the functional lens receptor for ATP (9).
The effect of ATP on Na-K-ATPase function was measured using two different approaches. Ouabain-sensitive 86Rb uptake and ATP hydrolysis both were increased. In the ATP hydrolysis assay, the ion concentration is defined and Na-K-ATPase activity is measured under identical Vmax conditions for both control epithelium and the epithelium taken from ATP-treated lenses. Therefore, the observed increase in Na-K-ATPase activity cannot be due to changes in sodium concentration. The increased Na-K-ATPase activity observed in the epithelium of ATP-treated lenses suggests that the activity of the Na-K-ATPase protein itself could have been modified following purinergic receptor stimulation in the intact lens. We cannot rule out, however, the possibility that the ATP-induced increase in Na-K-ATPase activity observed in this study is due in part to a shift in Na-K-ATPase protein from intracellular trafficking vesicles to the plasma membrane. Na-K-ATPase activity might go undetected in sealed membrane compartments and while alamethicin was added to the Na-K-ATPase assay solution to permeabilize membranes (47), the effectiveness of alamethicin in permeabilizing trafficking vesicles is currently unknown. In several cell types, the capacity for Na-K-ATPase-mediated ion transport is changed by translocation of Na-K-ATPase
-subunit molecules into or out of the plasma membrane (14, 37). PKA and PKC have been shown to be involved in this process (21, 42). PKC is known to be activated following purinergic receptor stimulation (38). SFKs have been shown to be upstream of PKC in certain signaling pathways (39, 46). PKC delta has been reported to be phosphorylated and activated by SFKs (28). While SFKs are unlikely to directly phosphorylate other PKC isoforms, SFKs can indirectly activate PKCs. For example, conventional PKCs are activated following activation of phospholipase C (PLC) (28) and others have shown that SFKs can activate PLC-
(6, 29), resulting in indirect activation of conventional PKCs. SFKs have also been shown to be involved in the transactivation of several receptor tyrosine kinases such as the EGFR, which in turn activates various signaling molecules, including the PKC (26, 46). Furthermore, Montiel et al. (31) proposed that SFK activation occurs upstream of PKC-
activation following P2Y receptor stimulation in the human umbilical vein endothelial cells. Further studies are required to determine whether PKC activation is involved in the chain of events between SFK activation and the regulation of Na-K-ATPase function in the ATP-treated intact lens.
Both ATP and UTP activated SFKs in lens epithelium as judged by an increase in the band density of PY416-Src immunoreactive proteins. The PY416-Src antibody does not discriminate between different Src family members but different Src family members have slightly different molecular weights (43). Despite this, a single PY416-Src immunoreactive band at
60 kDa was observed in the epithelium of ATP-treated lenses, suggesting that not all Src family members are activated. There was no evidence for activation of p53/56Lyn or p56Lck because this would have given rise to PY416-SFK bands that migrate to different positions. SFKs have been shown to be activated following purinoceptor stimulation in various other cell types (7, 19, 22, 26). Members of the Src kinase family activated following purinoceptor stimulation appear to differ according to the tissue or cell type as well as the purinergic receptor. In neuroblastoma cells, stimulation of P2Y11 results in activation of Yes (22), while P2Y2 receptor stimulation results in the activation of Src in astrocytoma cells as well as hepatocytes (7, 26). In platelets, Src is activated by P2Y1 stimulation but not P2Y12 (19). Lens cells have been reported to express P2Y2 receptors (9–11). In the present study, Western blot analysis of immunoprecipitated SFK members revealed that ATP induces active site phosphorylation of Src, and to a lesser extent Fyn, in the epithelium of organ-cultured rabbit lenses. No significant change of Yes phosphorylation was detected. This suggests that in the lens epithelium ATP selectively activates Src and Fyn.
The ATP-induced increase in ouabain-sensitive potassium (86Rb) uptake was abolished by PP2, a SFK inhibitor previously shown to completely inhibit SFK activity of porcine lens homogenates in vitro (41). The ability of PP2 to suppress the 86Rb uptake response indicates that SFK activation is involved in the observed increase in 86Rb uptake. Results from this study point to the involvement of Src and/or Fyn. While Na-K-ATPase protein can be phosphorylated and the activity modified by SFK-induced phosphorylation in vitro (4, 5, 17), immunoprecipitation and Western blot analysis did not reveal a sustained increase in tyrosine phosphorylation of Na-K-ATPase
1 subunit in the epithelium of lenses that had been exposed to ATP. Thus, while the result with PP2 indicates that SFKs are involved in the signaling pathway leading to the increase in Na-K-ATPase function induced by ATP, it seems unlikely that the change of Na-K-ATPase activity is simply the result of SFK-induced tyrosine phosphorylation of Na-KATPase protein. Na-K-ATPase regulation is complex and PKC, PKA, Akt, and extracellular signal-regulated kinase (ERK) have all been shown to influence Na-K-ATPase in other cell types (1, 3, 23, 42). SFKs have shown to be upstream of these kinases in signaling pathways in various cell types (2, 8, 31). Akt and ERK are both activated following ATP-treatment of the intact lens (data not shown) but further studies will be required to examine their possible involvement in the observed purinergic agonist-mediated stimulation of Na-K-ATPase function.
It is interesting that findings from various laboratories suggest that SFKs, especially Src, play a pivotal role in initiating a signaling cascade activated by interaction of cardiac glycosides, such as ouabain, with Na-K-ATPase. Typically, these responses are initiated by concentrations of ouabain that are too low to cause significant inhibition of Na-K-ATPase-mediated ion transport, suggesting that ouabain is affecting the Na-K-ATPase in a different manner. Consistent with this finding, low concentrations of ouabain cause binding of Src to Na-K-ATPase
-subunit and activation of Src, followed by ERK activation in several cell types (18). Kotova and colleagues (20) showed recently that Src activation in ouabain-treated human skeletal muscle cells involves PP2-sensitive Na-K-ATPase
-subunit tyrosine phosphorylation, a step that is important for the Src/Na-K-ATPase signal complex formation. These studies point to interactions between SFKs and Na-K-ATPase
-subunit. Xie and colleagues (25, 27) have proposed that Na-K-ATPase molecules involved in signal transduction could be different from the Na-K-ATPase molecules responsible for ion transport. These authors suggest that signal transducing Na-K-ATPase resides in the caveolae and is unlikely to be involved in sodium and potassium transport.
Regulation of Na-K-ATPase activity by tyrosine kinases is not limited to the lens. Feraille and colleagues (15, 16) have shown that insulin-induced stimulation of ouabain-sensitive 86Rb uptake in proximal tubule cells is tyrosine kinase dependent and involves the phosphorylation of the Tyr10 residue of the Na-K-ATPase
-subunit. Inhibition of Na-K-ATPase by thrombin or endothelin in the lens as well as by dopamine in the ciliary nonpigmented epithelial cells was relieved by the tyrosine kinase inhibitor genistein (32, 34, 35). SFK members have also been implicated in stimulation of Na-K-ATPase activity in alveolar epithelial cells and cortical neurons (23, 45). It is worth noting that different isoforms of the Na-K-ATPase
subunit may respond in different ways. Wang and Yu (45) have reported that Lyn causes an increase of Na-K-ATPase
3 isoform activity in rat cortical neurons while Bozulic et al. (4) observed inhibition of Na-K-ATPase
1 subunit activity in porcine lens. This adds further complication by demonstrating that not only can different SFK members affect a particular isoform of the
subunit differently (5) but also each isoform of the
subunit might react differently to a particular SFK member. In the rabbit lens used in the present study,
1 is the major isoform with low levels of
2 and
3 expression.
In summary, purinergic receptor stimulation results in increased activity of the Na-K-ATPase in the organ-cultured rabbit lens. The Src family of tyrosine kinases is involved in the chain of events between the purinergic receptor and the Na-K-ATPase. Results from the present study point to a role for Src and Fyn. Src has earlier been demonstrated to increase Na-K-ATPase activity in porcine lens membrane material (5). Previously, we have shown tyrosine kinase-dependent inhibition of Na-K-ATPase by thrombin and endothelin (34, 35). ATP and endothelin have been shown to be released by lens cells and therefore could be involved in the physiological regulation of the lens Na-K-ATPase in an autocrine fashion (13, 36). ATP is released under stress (13) and is likely to leak out of damaged or injured cells. The stimulation of Na-K-ATPase activity by ATP will reestablish the sodium gradient which is required for cotransport and countertransport of various molecules, such as osmolytes, calcium, glucose, or amino acids, which are required for volume regulation following osmotic stress or for cell growth during wound healing after injury.
| GRANTS |
|---|
|
|
|---|
| ACKNOWLEDGMENTS |
|---|
| FOOTNOTES |
|---|
The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
* S. Tamiya and M. C. Okafor contributed equally to this work. ![]()
| REFERENCES |
|---|
|
|
|---|
2. Arthur DB, Georgi S, Akassoglou K, Insel PA. Inhibition of apoptosis by P2Y2 receptor activation: novel pathways for neuronal survival. J Neurosci 26: 3798–3804, 2006.
3. Bertorello AM, Katz AI. Short-term regulation of renal Na-K-ATPase activity: physiological relevance and cellular mechanisms. Am J Physiol Renal Fluid Electrolyte Physiol 265: F743–F755, 1993.
4. Bozulic LD, Dean WL, Delamere NA. The influence of Lyn kinase on Na,K-ATPase in porcine lens epithelium. Am J Physiol Cell Physiol 286: C90–C96, 2004.
5. Bozulic LD, Dean WL, Delamere NA. The influence of SRC-family tyrosine kinases on Na,K-ATPase activity in lens epithelium. Invest Ophthalmol Vis Sci 46: 618–622, 2005.
6. Buitrago C, Gonzalez Pardo V, de Boland AR. Nongenomic action of 1
,25(OH)(2)-vitamin D3. Activation of muscle cell PLC gamma through the tyrosine kinase c-Src and PtdIns 3-kinase. Eur J Biochem 269: 2506–2515, 2002.[ISI][Medline]
7. Carini R, Alchera E, De Cesaris MG, Splendore R, Piranda D, Baldanzi G, Albano E. Purinergic P2Y2 receptors promote hepatocyte resistance to hypoxia. J Hepatol 45: 236–245, 2006.[CrossRef][ISI][Medline]
8. Chen KC, Zhou Y, Zhang W, Lou MF. Control of PDGF-induced reactive oxygen species (ROS) generation and signal transduction in human lens epithelial cells. Mol Vis 13: 374–387, 2007.[ISI][Medline]
9. Churchill GC, Louis CF. Stimulation of P2U purinergic or alpha 1A adrenergic receptors mobilizes Ca2+ in lens cells. Invest Ophthalmol Vis Sci 38: 855–865, 1997.
10. Collison DJ, Duncan G. Regional differences in functional receptor distribution and calcium mobilization in the intact human lens. Invest Ophthalmol Vis Sci 42: 2355–2363, 2001.
11. Cowlen MS, Zhang VZ, Warnock L, Moyer CF, Peterson WM, Yerxa BR. Localization of ocular P2Y2 receptor gene expression by in situ hybridization. Exp Eye Res 77: 77–84, 2003.[CrossRef][ISI][Medline]
12. Duncan G, Bushell AR. Ion analyses of human cataractous lenses. Exp Eye Res 20: 223–230, 1975.[CrossRef][ISI][Medline]
13. Eldred JA, Sanderson J, Wormstone M, Reddan JR, Duncan G. Stress-induced ATP release from and growth modulation of human lens and retinal pigment epithelial cells. Biochem Soc Trans 31: 1213–1215, 2003.[ISI][Medline]
14. Ewart HS, Klip A. Hormonal regulation of the Na+-K+-ATPase: mechanisms underlying rapid and sustained changes in pump activity. Am J Physiol Cell Physiol 269: C295–C311, 1995.
15. Feraille E, Carranza ML, Gonin S, Beguin P, Pedemonte C, Rousselot M, Caverzasio J, Geering K, Martin PY, Favre H. Insulin-induced stimulation of Na+,K+-ATPase activity in kidney proximal tubule cells depends on phosphorylation of the alpha-subunit at Tyr-10. Mol Biol Cell 10: 2847–2859, 1999.
16. Feraille E, Carranza ML, Rousselot M, Favre H. Modulation of Na+,K+-ATPase activity by a tyrosine phosphorylation process in rat proximal convoluted tubule. J Physiol 498: 99–108, 1997.
17. Ferrandi M, Molinari I, Barassi P, Minotti E, Bianchi G, Ferrari P. Organ hypertrophic signaling within caveolae membrane subdomains triggered by ouabain and antagonized by PST 2238. J Biol Chem 279: 33306–33314, 2004.
18. Haas M, Askari A, Xie Z. Involvement of Src and epidermal growth factor receptor in the signal-transducing function of Na+/K+-ATPase. J Biol Chem 275: 27832–27837, 2000.
19. Hardy AR, Jones ML, Mundell SJ, Poole AW. Reciprocal cross-talk between P2Y1 and P2Y12 receptors at the level of calcium signaling in human platelets. Blood 104: 1745–1752, 2004.
20. Kotova O, Al-Khalili L, Talia S, Hooke C, Fedorova OV, Bagrov AY, Chibalin AV. Cardiotonic steroids stimulate glycogen synthesis in human skeletal muscle cells via a Src- and ERK1/2-dependent mechanism. J Biol Chem 281: 20085–20094, 2006.
21. Kristensen B, Birkelund S, Jorgensen PL. Trafficking of Na,K-ATPase fused to enhanced green fluorescent protein is mediated by protein kinase A or C. J Membr Biol 191: 25–36, 2003.[CrossRef][ISI][Medline]
22. Lakshmi S, Joshi PG. Activation of Src/kinase/phospholipase C/mitogen-activated protein kinase and induction of neurite expression by ATP, independent of nerve growth factor. Neuroscience 141: 179–189, 2006.[CrossRef][ISI][Medline]
23. Lei J, Mariash CN, Ingbar DH. 3,3',5-Triiodo-L-thyronine up-regulation of Na,K-ATPase activity and cell surface expression in alveolar epithelial cells is Src kinase- and phosphoinositide 3-kinase-dependent. J Biol Chem 279: 47589–47600, 2004.
24. Leipziger J. Control of epithelial transport via luminal P2 receptors. Am J Physiol Renal Physiol 284: F419–F432, 2003.
25. Liang M, Tian J, Liu L, Pierre S, Liu J, Shapiro J, Xie ZJ. Identification of a pool of non-pumping Na/K-ATPase. J Biol Chem 282: 10585–10593, 2007.
26. Liu J, Liao Z, Camden J, Griffin KD, Garrad RC, Santiago-Perez LI, Gonzalez FA, Seye CI, Weisman GA, Erb L. Src homology 3 binding sites in the P2Y2 nucleotide receptor interact with Src and regulate activities of Src, proline-rich tyrosine kinase 2, and growth factor receptors. J Biol Chem 279: 8212–8218, 2004.
27. Liu L, Mohammadi K, Aynafshar B, Wang H, Li D, Liu J, Ivanov AV, Xie Z, Askari A. Role of caveolae in signal-transducing function of cardiac Na+/K+-ATPase. Am J Physiol Cell Physiol 284: C1550–C1560, 2003.
28. Liu WS, Heckman CA. The sevenfold way of PKC regulation. Cell Signal 10: 529–542, 1998.[CrossRef][ISI][Medline]
29. Marrero MB, Schieffer B, Paxton WG, Schieffer E, Bernstein KE. Electroporation of pp60c-src antibodies inhibits the angiotensin II activation of phospholipase C-
1 in rat aortic smooth muscle cells. J Biol Chem 270: 15734–15738, 1995.
30. Mitchell CH, Carre DA, McGlinn AM, Stone RA, Civan MM. A release mechanism for stored ATP in ocular ciliary epithelial cells. Proc Natl Acad Sci USA 95: 7174–7178, 1998.
31. Montiel M, de la Blanca EP, Jimenez E. P2Y receptors activate MAPK/ERK through a pathway involving PI3K/PDK1/PKC-zeta in human vein endothelial cells. Cell Physiol Biochem 18: 123–134, 2006.[CrossRef][ISI][Medline]
32. Nakai Y, Dean WL, Hou Y, Delamere NA. Genistein inhibits the regulation of active sodium-potassium transport by dopaminergic agonists in nonpigmented ciliary epithelium. Invest Ophthalmol Vis Sci 40: 1460–1466, 1999.
33. Nakata H. Mitogen-activated protein kinase signaling is involved in suramin-induced neurite outgrowth in a neuronal cell line. Biochem Biophys Res Commun 355: 842–848, 2007.[CrossRef][ISI][Medline]
34. Okafor MC, Dean WL, Delamere NA. Thrombin inhibits active sodium-potassium transport in porcine lens. Invest Ophthalmol Vis Sci 40: 2033–2038, 1999.
35. Okafor MC, Delamere NA. The inhibitory influence of endothelin on active sodium-potassium transport in porcine lens. Invest Ophthalmol Vis Sci 42: 1018–1023, 2001.
36. Okafor MC, Mukhopadhyay P, Delamere NA. Studies on endothelin release and Na,K transport in porcine lens. Invest Ophthalmol Vis Sci 43: 790–796, 2002.
37. Pedemonte CH, Efendiev R, Bertorello AM. Inhibition of Na,K-ATPase by dopamine in proximal tubule epithelial cells. Semin Nephrol 25: 322–327, 2005.[CrossRef][ISI][Medline]
38. Ralevic V, Burnstock G. Receptors for purines and pyrimidines. Pharmacol Rev 50: 413–492, 1998.
39. Reuss B, von Bohlen A, Halbach O. Fibroblast growth factors and their receptors in the central nervous system. Cell Tissue Res 313: 139–157, 2003.[CrossRef][ISI][Medline]
40. Tamiya S, Delamere NA. The influence of sodium-calcium exchange inhibitors on rabbit lens ion balance and transparency. Exp Eye Res 83: 1089–1095, 2006.[CrossRef][ISI][Medline]
41. Tamiya S, Delamere NA. Studies of tyrosine phosphorylation and Src family tyrosine kinases in the lens epithelium. Invest Ophthalmol Vis Sci 46: 2076–2081, 2005.
42. Therien AG, Blostein R. Mechanisms of sodium pump regulation. Am J Physiol Cell Physiol 279: C541–C566, 2000.
43. Thomas SM, Brugge JS. Cellular functions regulated by Src family kinases. Annu Rev Cell Dev Biol 13: 513–609, 1997.[CrossRef][ISI][Medline]
44. von Kugelgen I, Wetter A. Molecular pharmacology of P2Y-receptors. Naunyn Schmiedebergs Arch Pharmacol 362: 310–323, 2000.[CrossRef][ISI][Medline]
45. Wang XQ, Yu SP. Novel regulation of Na,K-ATPase by Src tyrosine kinases in cortical neurons. J Neurochem 93: 1515–1523, 2005.[CrossRef][ISI][Medline]
46. Xie Z. Molecular mechanisms of Na/K-ATPase-mediated signal transduction. Ann NY Acad Sci 986: 497–503, 2003.
47. Xie ZJ, Wang YH, Ganjeizadeh M, McGee R Jr, Askari A. Determination of total (Na+ + K+)-ATPase activity of isolated or cultured cells. Anal Biochem 183: 215–219, 1989.[CrossRef][ISI][Medline]
48. Zhuang S, Schnellmann RG. Suramin promotes proliferation and scattering of renal epithelial cells. J Pharmacol Exp Ther 314: 383–390, 2005.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |